Clinical Trial

Breast Mesh Used in Two-staged Breast Reconstruction

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 20, 2021 (before its estimated August 1, 2023 completion). Its status may not reflect the trial's current state.
Summary
This is the first prospective randomized and controlled study on the efficacy and safety of TiLOOP® Bra mesh in patients with expander-implant breast reconstruction. The investigators hypothesize that incoporating TiLOOP Bra mesh with tissue expanders will reduce the rates of capsular contraction, improve the efficiency of expansion and provide better aesthetic result.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT04967976
Lead Sponsor Tianjin Medical University Cancer Institute and Hospital
Conditions Breast Cancer, Radiation, Breast Reconstruction, Synthetic Mesh
Enrollment 300 participants
Start Date 2021-08-01
Primary Completion 2023-08-01 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2021-07-20